Treatment with cationic liposome-DNA complexes (CLDCs) protects mice from lethal Western equine encephalitis virus (WEEV) challenge

Antiviral Research

Volumn 87, Issue 2, 2010, Pages 195-203

  Logue, Christopher H ^a,b   Phillips, Aaron T ^b   Mossel, Eric C ^a,b   Ledermann, Jeremy P ^a   Welte, Thomas ^b   Dow, Steve W ^b   Olson, Ken E ^b   Powers, Ann M ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

Alphavirus; CLDC; Immunotherapy; WEEV

Indexed keywords

ANTIVIRUS AGENT; CATIONIC LIPOSOME DNA COMPLEX; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; DNA; DRUG CARRIER; IMMUNOLOGIC FACTOR; LIPOSOME;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNOTHERAPY; INNATE IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; TH1 CELL; VIRUS CHARACTERIZATION; VIRUS ENCEPHALITIS; VIRUS STRAIN; WESTERN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; ANIMAL; BLOOD; BRAIN; DISEASE MODEL; ENCEPHALOMYELITIS, EQUINE; GENETICS; IMMUNOLOGY; PROCEDURES; SURVIVAL;

ANIMALS; BLOOD; BRAIN; CYTOKINES; DISEASE MODELS, ANIMAL; DNA; DRUG CARRIERS; ENCEPHALITIS VIRUS, WESTERN EQUINE; ENCEPHALOMYELITIS, EQUINE; FEMALE; IMMUNOLOGIC FACTORS; IMMUNOTHERAPY; LIPOSOMES; MICE; SURVIVAL ANALYSIS;

ALPHAVIRUS; ANIMALIA; MUS; WESTERN EQUINE ENCEPHALOMYELITIS VIRUS;

EID: 77954954743     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2010.04.013     Document Type: Article

References (52)

1. Akira S., Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 2004, 4:499-511.
2. Aliberti J., Reis e Sousa C., Schito M., Hieny S., Wells T., Huffnagle G.B., Sher A. CCR5 provides a signal for microbial induced production of IL-12 by CD8 alpha+ dendritic cells. Nat. Immunol. 2000, 1:83-87.
3. Barry G., Breakwell L., Fragkoudis R., Attarzadeh-Yazdi G., Rodriguez-Andres J., Kohl A., Fazakerley J.K. PKR acts early in infection to suppress Semliki Forest virus production and strongly enhances the type I interferon response. J. Gen. Virol. 2009, 90:1382-1391.
4. Bernstein D.I., Cardin R.D., Bravo F.J., Strasser J.E., Farley N., Chalk C., Lay M., Fairman J. Potent adjuvant activity of cationic liposome-DNA complexes for genital herpes vaccines. Clin. Vac. Immunol. 2009, 16:699-705.
5. Burdeinick-Kerr R., Govindarajan D., Griffin D.E. Noncytolytic clearance of sindbis virus infection from neurons by gamma interferon is dependent on Jak/STAT signaling. J. Virol. 2009, 83:3429-3435.
6. Burdeinick-Kerr R., Griffin D.E. Gamma interferon-dependent, noncytolytic clearance of sindbis virus infection from neurons in vitro. J. Virol. 2005, 79:5374-5385.
7. Burke C.W., Gardner C.L., Steffan J.J., Ryman K.D., Klimstra W.B. Characteristics of alpha/beta interferon induction after infection of murine fibroblasts with wild-type and mutant alphaviruses. Virology 2009, 395:121-132.
8. Calisher C.H., Karabatsos N., Lazuick J.S., Monath T.P., Wolff K.L. Reevaluation of the western equine encephalitis antigenic complex of alphaviruses (family Togaviridae) as determined by neutralization tests. Am. J. Trop. Med. Hyg. 1988, 38:447-452.
9. Chomarat P., Rissoan M.C., Banchereau J., Miossec P. Interferon gamma inhibits interleukin 10 production by monocytes. J. Exp. Med. 1993, 177:523-527.
10. Donnelly R.P., Freeman S.L., Hayes M.P. Inhibition of IL-10 expression by IFN-gamma up-regulates transcription of TNF-alpha in human monocytes. J. Immunol. 1995, 155:1420-1427.
11. Dow S.W., Fradkin L.G., Liggitt D.H., Willson A.P., Heath T.D., Potter T.A. Lipid-DNA complexes induce potent activation of innate immune responses and antitumor activity when administered intravenously. J. Immunol. 1999, 163:1552-1561.
12. Fairman J., Moore J., Lemieux M., Van R.K., Geng Y., Warner J., Abel K. Enhanced in vivo immunogenicity of SIV vaccine candidates with cationic liposome-DNA complexes in a rhesus macaque pilot study. Hum. Vac. 2009, 5:141-150.
13. Fiorentino D.F., Bond M.W., Mosmann T.R. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 1989, 170:2081-2095.
14. Fitzgerald-Bocarsly P. Natural interferon-alpha producing cells: the plasmacytoid dendritic cells. Biotechniques 2002, (Suppl. 16-20, 22, 24-29):16-19.
15. Goodyear A., Jones A., Troyer R., Bielefeldt-Ohmann H., Dow S. Critical protective role for MCP-1 in pneumonic Burkholderia mallei infection. J. Immunol. 2010, 184:1445-1454.
16. Goodyear A., Kellihan L., Bielefeldt-Ohmann H., Troyer R., Propst K., Dow S. Protection from pneumonic infection with burkholderia species by inhalational immunotherapy. Infect. Immun. 2009, 77:1579-1588.
17. Gowen B.B., Fairman J., Dow S., Troyer R., Wong M.H., Jung K.H., Melby P.C., Morrey J.D. Prophylaxis with cationic liposome-DNA complexes protects hamsters from phleboviral disease: importance of liposomal delivery and CpG motifs. Antiviral Res. 2009, 81:37-46.
18. Gowen B.B., Fairman J., Smee D.F., Wong M.H., Jung K.H., Pace A.M., Heiner M.L., Bailey K.W., Dow S.W., Sidwell R.W. Protective immunity against acute phleboviral infection elicited through immunostimulatory cationic liposome-DNA complexes. Antiviral Res. 2006, 69:165-172.
19. Gursel I., Gursel M., Ishii K.J., Klinman D.M. Sterically stabilized cationic liposomes improve the uptake and immunostimulatory activity of CpG oligonucleotides. J. Immunol. 2001, 167:3324-3328.
20. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., Akira S. A Toll-like receptor recognizes bacterial DNA. Nature 2000, 408:740-745.
21. Honda K., Yanai H., Negishi H., Asagiri M., Sato M., Mizutani T., Shimada N., Ohba Y., Takaoka A., Yoshida N., Taniguchi T. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 2005, 434:772-777.
22. Ishii K.J., Akira S. Innate immune recognition of, and regulation by, DNA. Trends Immunol. 2006, 27:525-532.
23. Ito T., Wang Y.H., Liu Y.J. Plasmacytoid dendritic cell precursors/type I interferon-producing cells sense viral infection by Toll-like receptor (TLR) 7 and TLR9. Springer Semin. Immunopathol. 2005, 26:221-229.
24. Johnston C., Jiang W., Chu T., Levine B. Identification of genes involved in the host response to neurovirulent alphavirus infection. J. Virol. 2001, 75:10431-10445.
25. Julander J.G., Siddharthan V., Blatt L.M., Schafer K., Sidwell R.W., Morrey J.D. Effect of exogenous interferon and an interferon inducer on western equine encephalitis virus disease in a hamster model. Virology 2007, 360:454-460.
26. Konopka J.L., Thompson J.M., Whitmore A.C., Webb D.L., Johnston R.E. Acute infection with venezuelan equine encephalitis virus replicon particles catalyzes a systemic antiviral state and protects from lethal virus challenge. J. Virol. 2009, 83:12432-12442.
27. Krieg A.M. A role for Toll in autoimmunity. Nat. Immunol. 2002, 3:423-424.
28. Krieg A.M. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 2002, 20:709-760.
29. Lanuti M., Rudginsky S., Force S.D., Lambright E.S., Siders W.M., Chang M.Y., Amin K.M., Kaiser L.R., Scheule R.K., Albelda S.M. Cationic lipid:bacterial DNA complexes elicit adaptive cellular immunity in murine intraperitoneal tumor models. Cancer Res. 2000, 60:2955-2963.
30. Logue C.H., Bosio C.F., Welte T., Keene K.M., Ledermann J.P., Phillips A., Sheahan B.J., Pierro D.J., Marlenee N., Brault A.C., Bosio C.M., Singh A.J., Powers A.M., Olson K.E. Virulence variation among isolates of western equine encephalitis virus in an outbred mouse model. J. Gen. Virol. 2009, 90:1848-1858.
31. Morrey J.D., Motter N.E., Taro B., Lay M., Fairman J. Efficacy of cationic lipid-DNA complexes (CLDC) on hepatitis B virus in transgenic mice. Antiviral Res. 2008, 79:71-79.
32. Murphy E.E., Terres G., Macatonia S.E., Hsieh C.S., Mattson J., Lanier L., Wysocka M., Trinchieri G., Murphy K., O'Garra A. B7 and interleukin 12 cooperate for proliferation and interferon gamma production by mouse T helper clones that are unresponsive to B7 costimulation. J. Exp. Med. 1994, 180:223-231.
33. Reed D.S., Larsen T., Sullivan L.J., Lind C.M., Lackemeyer M.G., Pratt W.D., Parker M.D. Aerosol exposure to western equine encephalitis virus causes fever and encephalitis in cynomolgus macaques. J. Infect. Dis. 2005, 192:1173-1182.
34. Reisen W.K., Kramer L.D., Chiles R.E., Green E.G., Martinez V.M. Encephalitis virus persistence in California birds: preliminary studies with house finches. J. Med. Entomol. 2001, 38:393-399.
35. Reisen W.K., Monath T.P. Western equine encephalomyelitis. The Arboviruses: Epidemiology and Ecology 1988, 89-137. CRC Press, Boca Raton, FL. T.P. Monath (Ed.).
36. Ryman K.D., Meier K.C., Gardner C.L., Adegboyega P.A., Klimstra W.B. Non-pathogenic Sindbis virus causes hemorrhagic fever in the absence of alpha/beta and gamma interferons. Virology 2007, 368:273-285.
37. Satoh J., Nanri Y., Tabunoki H., Yamamura T. Microarray analysis identifies a set of CXCR3 and CCR2 ligand chemokines as early IFNbeta-responsive genes in peripheral blood lymphocytes in vitro: an implication for IFNbeta-related adverse effects in multiple sclerosis. BMC Neurol. 2006, 19(6):18.
38. Schroder K., Hertzog P.J., Ravasi T., Hume D.A. Interferon-gamma: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 2004, 75:163-189.
39. Seitz M., Loetscher P., Dewald B., Towbin H., Gallati H., Baggiolini M. Interleukin-10 differentially regulates cytokine inhibitor and chemokine release from blood mononuclear cells and fibroblasts. Eur. J. Immunol. 1995, 25:1129-1132.
40. Sidwell R.W., Smee D.F. Viruses of the Bunya- and Togaviridae families: potential as bioterrorism agents and means of control. Antiviral Res. 2003, 57:101-111.
41. Simmons J.D., White L.J., Morrison T.E., Montgomery S.A., Whitmore A.C., Johnston R.E., Heise M.T. Venezuelan equine encephalitis virus disrupts STAT1 signaling by distinct mechanisms independent of host shutoff. J. Virol. 2009, 83:10571-10581.
42. Stetson D.B., Medzhitov R. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 2006, 24:93-103.
43. Takaoka A., Taniguchi T. Cytosolic DNA recognition for triggering innate immune responses. Adv. Drug Deliv. Rev. 2008, 60:847-857.
44. Takaoka A., Wang Z., Choi M.K., Yanai H., Negishi H., Ban T., Lu Y., Miyagishi M., Kodama T., Honda K., Ohba Y., Taniguchi T. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 2007, 448:501-505.
45. Takeshita F., Leifer C.A., Gursel I., Ishii K.J., Takeshita S., Gursel M., Klinman D.M. Cutting edge: role of Toll-like receptor 9 in CpG DNA-induced activation of human cells. J. Immunol. 2001, 167:3555-3558.
46. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 2003, 3:133-146.
47. Wang R.F., Miyahara Y., Wang H.Y. Toll-like receptors and immune regulation: implications for cancer therapy. Oncogene 2008, 27:181-189.
48. Whitmore M., Li S., Huang L. LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth. Gene Ther. 1999, 6:1867-1875.
49. Whitmore M.M., Li S., Falo L., Huang L. Systemic administration of LPD prepared with CpG oligonucleotides inhibits the growth of established pulmonary metastases by stimulating innate and acquired antitumor immune responses. Cancer Immunol. Immunother. 2001, 50:503-514.
50. Yasuda K., Ogawa Y., Yamane I., Nishikawa M., Takakura Y. Macrophage activation by a DNA/cationic liposome complex requires endosomal acidification and TLR9-dependent and -independent pathways. J. Leukoc. Biol. 2005, 77:71-79.
51. Zaks K., Jordan M., Guth A., Sellins K., Kedl R., Izzo A., Bosio C., Dow S. Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 or TLR9 agonists complexed to cationic liposomes. J. Immunol. 2006, 176:7335-7345.
52. Zhu N., Liggitt D., Liu Y., Debs R. Systemic gene expression after intravenous DNA delivery into adult mice. Science 1993, 261:209-211.